Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Journal of the American Society of Nephrology : JASN|October 20, 2021
B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant RecipientsEva Schrezenmeier, Hector Rincon-Arevalo, Ana-Luisa Stefanski, et al.
Frontiers in Immunology|July 19, 2021
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic DialysisEva Schrezenmeier, Leon Bergfeld, David Hillus, et al.
Journal of Visualized Experiments : Jove|April 26, 2021
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS PlatformWiebke Duettmann, Marcel G Naik, Danilo Schmidt, et al.
Hypertension (Dallas, Tex. : 1979)|September 4, 2014
Bcl10 mediates angiotensin II-induced cardiac damage and electrical remodelingLajos Markó, Norbert Henke, Joon-Keun Park, et al.
The Journal of Clinical Investigation|June 8, 2021
Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipientsArne Sattler, Eva Schrezenmeier, Ulrike A Weber, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
Science Immunology|June 16, 2021
Impaired humoral immunity to SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients and dialysis patientsHector Rincon-Arevalo, Mira Choi, Ana-Luisa Stefanski, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2024
Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trialAylin Akifova, Klemens Budde, Kerstin Amann, et al.
Pageof 12